Cargando…
Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy
PURPOSE: The aim of this study was to evaluate the possible risk factors for developing a parastomal hernia (PSH) in a cohort of rectal cancer patients with and without the application of a retro-muscular prophylactic mesh. The evaluated risk factors included the position of the stoma in the rectus...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012864/ https://www.ncbi.nlm.nih.gov/pubmed/35381884 http://dx.doi.org/10.1007/s10029-022-02580-3 |
_version_ | 1784687881144500224 |
---|---|
author | Täckström, S. Chabok, A. Smedh, K. Nikberg, M. |
author_facet | Täckström, S. Chabok, A. Smedh, K. Nikberg, M. |
author_sort | Täckström, S. |
collection | PubMed |
description | PURPOSE: The aim of this study was to evaluate the possible risk factors for developing a parastomal hernia (PSH) in a cohort of rectal cancer patients with and without the application of a retro-muscular prophylactic mesh. The evaluated risk factors included the position of the stoma in the rectus abdominis muscle (RAM), RAM atrophy and shift of abdominal wall midline structures. METHODS: Rectal cancer patients treated with an abdominoperineal excision or Hartmann’s procedure between 2002 and 2015 at Västmanland Hospital, Sweden was included. Postoperative CT examinations were retrospectively reviewed regarding the presence of PSH and RAM atrophy and for measurements such as position of the stoma in the RAM. RESULTS: 116 patients were included, with a median age of 71 years. 70 patients received a prophylactic stoma mesh. 55 patients (47%) had a parastomal hernia at three-year follow-up. Rectus abdominis muscle atrophy was significantly higher in the mesh group compared with the non-mesh group (37% vs 2%; P = 0.04). RAM atrophy was a significant independent protective factor for developing a PSH (P = 0.007; OR 0.15; 95% CI 0.03–0.55). CONCLUSION: Placement of a prophylactic retro-muscular stoma mesh resulted in a high frequency of RAM atrophy distal to the stomal aperture and patients with such atrophy had a lower risk of developing a PSH. |
format | Online Article Text |
id | pubmed-9012864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Paris |
record_format | MEDLINE/PubMed |
spelling | pubmed-90128642022-05-02 Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy Täckström, S. Chabok, A. Smedh, K. Nikberg, M. Hernia Original Article PURPOSE: The aim of this study was to evaluate the possible risk factors for developing a parastomal hernia (PSH) in a cohort of rectal cancer patients with and without the application of a retro-muscular prophylactic mesh. The evaluated risk factors included the position of the stoma in the rectus abdominis muscle (RAM), RAM atrophy and shift of abdominal wall midline structures. METHODS: Rectal cancer patients treated with an abdominoperineal excision or Hartmann’s procedure between 2002 and 2015 at Västmanland Hospital, Sweden was included. Postoperative CT examinations were retrospectively reviewed regarding the presence of PSH and RAM atrophy and for measurements such as position of the stoma in the RAM. RESULTS: 116 patients were included, with a median age of 71 years. 70 patients received a prophylactic stoma mesh. 55 patients (47%) had a parastomal hernia at three-year follow-up. Rectus abdominis muscle atrophy was significantly higher in the mesh group compared with the non-mesh group (37% vs 2%; P = 0.04). RAM atrophy was a significant independent protective factor for developing a PSH (P = 0.007; OR 0.15; 95% CI 0.03–0.55). CONCLUSION: Placement of a prophylactic retro-muscular stoma mesh resulted in a high frequency of RAM atrophy distal to the stomal aperture and patients with such atrophy had a lower risk of developing a PSH. Springer Paris 2022-04-05 2022 /pmc/articles/PMC9012864/ /pubmed/35381884 http://dx.doi.org/10.1007/s10029-022-02580-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Täckström, S. Chabok, A. Smedh, K. Nikberg, M. Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title | Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title_full | Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title_fullStr | Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title_full_unstemmed | Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title_short | Use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
title_sort | use of prophylactic stoma mesh is a risk factor for developing rectus abdominis muscle atrophy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012864/ https://www.ncbi.nlm.nih.gov/pubmed/35381884 http://dx.doi.org/10.1007/s10029-022-02580-3 |
work_keys_str_mv | AT tackstroms useofprophylacticstomameshisariskfactorfordevelopingrectusabdominismuscleatrophy AT chaboka useofprophylacticstomameshisariskfactorfordevelopingrectusabdominismuscleatrophy AT smedhk useofprophylacticstomameshisariskfactorfordevelopingrectusabdominismuscleatrophy AT nikbergm useofprophylacticstomameshisariskfactorfordevelopingrectusabdominismuscleatrophy |